Nearly two-thirds of asymptomatic adults in a US safety-net health care system tested positive for Helicobacter pylori antibodies.

Primary OS analysis results from STELLAR-303 showed zanzalintinib + atezolizumab improved OS vs regorafenib in metastatic colorectal cancer.

The percentage of those with early-onset diverticulitis admitted for complicated diverticulitis went from 18.5% to 28.2% from 2005 to 2020.

Developers of biosimilars will no longer be required to conduct clinical trials to prove effectiveness for FDA approval.

Physicians with H-1B-sponsored visas accounted for 0.97% of physicians in the United States in fiscal year 2024.

The probability of developing ocular EIMs was comparable across treatment classes among patients with HLA-B27-associated diseases.

Tetrachloroethylene (PCE) exposure was linked to a tripled risk for significant liver fibrosis, with a dose-dependent effect.

Moderate-to-vigorous physical activity guideline adherence was associated with a 22% and 17% lower CHD risk in women and men, respectively.

Type 2 diabetes prevalence among children aged 5 years or less is associated with social and environmental factors.

Individuals with MetALD vs MASLD have significantly higher risks for liver-related events, liver cancer, and extrahepatic cancers.

Ustekinumab and vedolizumab have comparable safety and efficacy in older and younger adults with IBD, indicating that age should not be a deterrent for treatment.

The presence of metabolic dysfunction-associated steatotic liver disease may be a predictor of disease trajectory in patients with MACE.